The effects of clozapine on the GSK-3-mediated signaling pathway (Q40585064)

21 September 2017

The effects of clozapine on the GSK-3-mediated signaling pathway (English)

1 reference

21 September 2017

Ung Gu Kang

1

1 reference

21 September 2017

Myoung Suk Seo

2

1 reference

21 September 2017

Myoung-Sun Roh

3

1 reference

21 September 2017

Yeni Kim

4

1 reference

21 September 2017

Se Chang Yoon

5

1 reference

21 September 2017

Yong Sik Kim

6

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

21 September 2017

5

1 reference

based on heuristic

inferred from page(s)

published in

FEBS Letters

1 reference

21 September 2017

560

1 reference

21 September 2017

115-119

1 reference

21 September 2017

1-3

1 reference

Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900082-1

The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900082-1

Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900082-1

Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900082-1

21 January 2018

The renaissance of GSK3

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900082-1

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900082-1

The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900082-1

Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900082-1

Regulation of the protein kinase activity of Shaggy(Zeste-white3) by components of the wingless pathway in Drosophila cells and embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900082-1

Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900082-1

Biphasic changes in the Ser-9 phosphorylation of glycogen synthase kinase-3beta after electroconvulsive shock in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900082-1

The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900082-1

GSK-3: tricks of the trade for a multi-tasking kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900082-1

Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900082-1

Differential regulation of glycogen synthase kinase 3beta by insulin and Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900082-1

Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900082-1

Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900082-1

Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900082-1

Wnt-1 dependent activation of the survival factor NF-kappaB in PC12 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900082-1

10.1016/S0014-5793(04)00082-1

7 January 2021

Identifiers

DOI

1 reference

21 September 2017

1 reference